Результаты поиска

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.

The development of novel agents has transformed the treatment paradigm for multiple myeloma, with minimal residual disease (MRD) negativity now achievable across the entire disease spectrum. Bone marrow-based technologies to assess MRD, including approaches using next-generation flow and next-generation sequencing, have provided real-time clinical tools for the sensitive detection and monitoring of MRD in patients with multiple myeloma. Complementary liquid biopsy-based assays are now quickly progressing with some, such as mass spectrometry methods, being very close to clinical use, while othe

Symptom burden and health-related quality of life six months after hyperbaric oxygen therapy in cancer survivors with pelvic radiation injuries

Abstract Purpose Late radiation tissue injuries (LRTIs) after treatment for pelvic cancer may impair health related quality of life (HRQoL). Hyperbaric oxygen therapy is an adjuvant therapy for LRTIs, but limited studied. The aim of this study was to explore the development and association between symptoms of LRTI and HRQoL following hyperbaric oxygen treatment. Methods A pretest–posttest design was used to evaluate the changes in pelvic LRTIs and HRQoL from baseline (T1), immediately after treatment (T2) and at six-month follow-up (T3). EPIC and EORTC-QLQ-C30 were used to assess LRTIs and HRQ

Функциональные биомеханические испытания ножки и лодыжки в области физиотерапии и спортивных мер, интеграции сенсоров и психометрических свойств: систематический обзор.

Цели: Систематического обобщения имеющихся данных о функциональных биомеханических испытаниях ступни и лодыжки в физиотерапии и спорте с уделением особого внимания мерам по их результатам, совместимости с износимыми сенсорными технологиями и психометрическим свойствам. Методы: Мы проводили систематический обзор (PRRISMA-руководитель) PubMed, Web of Science, PEDro и SPORTDiscus с момента создания по декабрь. 2025. Приемлемые исследования позволили оценить функциональную биомеханику ног/огней ног у спортсменов, здоровых взрослых или взрослых, страдающих мускулоскелетными ступнями/огнями, с испол

Совпадение в полном тексте источника
… Measures of measurement error, including the standard error of measurement, were reported in a limited number of studies, while minimal detectable change and minimal clinically important difference were not reported. … Although minimal clinically important difference (MCID) values were not estimated, the absence of this metric did not compromise the validity of the findings. Cudejko et al. (2023) showed adequate to very good methodological rigour [ 15 ]. …

A Comprehensive Review of the Role of the Latest Minimally Invasive Neurosurgery Techniques and Outcomes for Brain and Spinal Surgeries.

Minimally invasive neurosurgical techniques offer reduced surgical trauma, lower complication rates, and faster recovery compared to traditional open procedures. Approaches such as keyhole craniotomy, endoscopic skull base surgery, endovascular neurosurgery, and percutaneous spinal techniques have advanced the management of cranial and spinal pathologies. These methods aim to minimize tissue disruption, blood loss, and hospital stay while maintaining surgical efficacy. This narrative review explores their evolution, applications, and advantages in modern neurosurgery.

Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma.

In the last years, the life expectancy of multiple myeloma (MM) patients has substantially improved thanks to the availability of many new drugs. Our ability to induce deep responses has improved as well, and the treatment goal in patients tolerating treatment moved from the delay of progression to the induction of the deepest possible response. As a result of these advances, a great scientific effort has been made to redefine response monitoring, resulting in the development and validation of high-sensitivity techniques to detect minimal residual disease (MRD). In 2016, the International Myel

Abstracts of the 28th Annual San Antonio Breast Cancer Symposium, December 8-11, 2005, San Antonio, Texas, USA.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Эффективность моделей машинного обучения для прогнозирования симптомов высокой чувствительности при множественном склерозе.

Текущий уход за многочисленными склерозами (МС) в первую очередь опирается на редко получаемые данные, такие, как магнитно-резонансная съемка, клинические лабораторные тесты или клиническая история, что приводит к незначительным изменениям, которые могут произойти в период между посещениями. Мобильные технологии позволяют осуществлять постоянный сбор данных и прокладывают путь к прогнозированию сложных аспектов НР, таких, как симптомы и заболевания. С этой целью мы провели первое в своем роде исследование по наблюдению под названием MS Mosail. Во-первых, мы разработали и публично запустили моб

AI-driven prognostics in pediatric bone marrow transplantation: a CAD approach with Bayesian and PSO optimization.

Bone marrow transplantation (BMT) is a critical treatment for various hematological diseases in children, offering a potential cure and significantly improving patient outcomes. However, the complexity of matching donors and recipients and predicting post-transplant complications presents significant challenges. In this context, machine learning (ML) and artificial intelligence (AI) serve essential functions in enhancing the analytical processes associated with BMT. This study introduces a novel Computer-Aided Diagnosis (CAD) framework that analyzes critical factors such as genetic compatibili

Нейрохирургические подходы к сбору тканей мозга для создания клеточной культуры в нейроэкспериментальных моделях клеток.

В последние десятилетия клеточная биология быстро прогрессировала. Методы изоляции и выращивания клеток, подкрепленные современными лабораторными процедурами и экспериментальными возможностями, обеспечивают широкий спектр возможностей для проведения исследований in vitro в целях изучения физиологических и патофизиологических процессов в области здоровья и болезней. Они также могут быть весьма эффективно использованы для анализа биоматериалов. До того как новый биоматериал будет готов для имплантации в ткани и широкого использования в клинической практике, он должен быть подвергнут тщательному

Evaluation of the Enhanced Recovery After Surgery (ERAS) Guidance for Patients With Spinal Metastasis.

Surgery continues to remain the most effective treatment for spinal metastasis (SM). As the number of surgeries continues to grow, the need for consensus guidelines for optimal perioperative care is imperative. Enhanced recovery after surgery (ERAS) protocols were created for this purpose. The objective of this study is to review evidence-based ERAS guidelines for SM surgery. A group of multiple experienced spine surgeons was invited to participate in this study. This group identified 19 ERAS items for SM surgery. The principal literature search utilized MEDLINE, Embase, and Cochrane databases

Advances in the assessment of minimal residual disease in mantle cell lymphoma.

The clinical impact of minimal residual disease detection at early time points or during follow-ups has been shown to accurately predict relapses among patients with lymphomas, mainly in follicular and diffuse large B cell lymphoma. The field of minimal residual disease testing in mantle cell lymphoma is still evolving but has great impact in determining the prognosis. Flow cytometry and polymerase chain reaction-based testing are most commonly used methods in practice; however, these methods are not sensitive enough to detect the dynamic changes that underline lymphoma progression. Newer meth

Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting.

Multiple Myeloma (MM) is a hematologic malignancy characterized by a wide clinical and biological heterogeneity leading to different patient outcomes. Various prognostic tools to stratify newly diagnosed (ND)MM patients into different risk groups have been proposed. At baseline, the standard-of-care prognostic score is the Revised International Staging System (R-ISS), which stratifies patients according to widely available serum markers (i.e., albumin, β 2-microglobulin, lactate dehydrogenase) and high-risk cytogenetic abnormalities detected by fluorescence in situ hybridization. Though this s

Contemporary treatment with radiosurgery for spine metastasis and spinal cord compression in 2015.

With the progress of image-guided localization, body immobilization system, and computerized delivery of intensity-modulated radiation delivery, it became possible to perform spine radiosurgery. The next question is how to translate the high technology treatment to the clinical application. Clinical trials have been performed to demonstrate the feasibility of spine radiosurgery and efficacy of the treatment in the setting of spine metastasis, leading to the randomized trials by a cooperative group. Radiosurgery has also demonstrated its efficacy to decompress the spinal cord compression in sel

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances.

Introduction: Acute lymphoblastic leukemia (ALL) is the first neoplasm where the assessment of early response to therapy by minimal residual disease (MRD) monitoring has proven to be a fundamental tool to guide therapeutic choices. The most standardized methods to study MRD in ALL are multi-parametric flow cytometry (MFC) and polymerase chain reaction (PCR) amplification-based methods. Emerging technologies hold the promise to improve MRD detection in ALL patients. Moreover, novel therapies, such as monoclonal antibodies, bispecific T-cell engagers, and chimeric antigen receptor T cells (CART)

Advancements in metastatic spinal cord compression treatment: a narrative review of innovations, challenges, and future directions.

ObjectiveTo synthesize recent advancements in metastatic spinal cord compression (MSCC) treatment, evaluating their efficacy in improving neurological function, pain relief, survival, and quality of life.BackgroundMSCC is an oncologic emergency caused by the progression of cancer to the spine and is prevalent in approximately 3-5% of all cancer patients, with a relatively higher incidence of breast, prostate, and lung cancers. MSCC can lead to irreversible paralysis due to loss of vital sensory and motor functions, thus requiring an immediate diagnosis and treatment.MethodsA systematic PubMed

Измеряемое остаточное заболевание гематологовых магнатов: биомаркер в поисках стандарта.

За последнее десятилетие измеримые остаточные заболевания (МРД) стали важнейшим инструментом обнаружения и мониторинга различных раковых заболеваний, но особенно гематологовых заболеваний. Быстрая адаптация этого новаторского подхода к мониторингу состояния заболеваний является интуитивно привлекательной: он обеспечивает значительно большую чувствительность по сравнению с традиционными методами обнаружения небольшого числа злокачественных клеток, которые сохраняются после лечения и которые не поддаются обнаружению с помощью таких стандартных подходов, как мониторинг аномалий на рентгенографиче

Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities.

Optimal control theory is branch of mathematics that aims to optimize a solution to a dynamical system. While the concept of using optimal control theory to improve treatment regimens in oncology is not novel, many of the early applications of this mathematical technique were not designed to work with routinely available data or produce results that can eventually be translated to the clinical setting. The purpose of this review is to discuss clinically relevant considerations for formulating and solving optimal control problems for treating cancer patients. Our review focuses on two of the mo

"Friends and foes" of multiple myeloma measurable/minimal residual disease evaluation by next generation flow.

Next Generation Flow (NGF) represents a gold standard for the evaluation of Minimal Residual Disease (MRD) in Multiple Myeloma (MM) patients at any stage of treatment. Although the assessment of MRD is still not universally employed in clinical practice, numerous studies have demonstrated the strength of MRD as a reliable predictor of long-term outcome, and its potential to supersede the prognostic value of CR. The possibility to acquire millions of events, in combination with the use of standard reagents and a good expertise in the analysis of rare populations, led to high chance of success a

Усиливающиеся тенденции измерения минимальных остаточных заболеваний при испытаниях, сосредоточенных на многократном лечении миеломы: систематический анализ клинических исследований 2014 в адрес 2025.

Минимальное остаточное заболевание (MRD) является центральным биомаркером миеломы (MM), обеспечивающим беспрецедентную чувствительность к оценке эффективности лечения и потенциальным суррогатным конечным пунктом. Мы провели всеобъемлющий анализ клинических испытаний, зарегистрированных на клинических предприятиях. 2014 и 2025. Были проведены оперативные испытания или исследования в области наблюдения, в ходе которых были расследованы терапевтические меры. Были получены данные о реакции на терапию, результатах MRD, измерении и их роли в качестве первичных, вторичных или адаптивных конечных точе

Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis.

PurposeMinimal residual disease (MRD) is a validated prognostic factor in several hematological malignancies. However, its role in systemic light chain (AL) amyloidosis remains controversial, and this systematic review and meta-analysis aims to fill this gap.MethodsWe searched for relevant studies on Pubmed, Embase, and Cochrane Controlled Register of Trials, nine studies involving 451 patients were included and meta-analyzed. This systematic review has been registered in PROSPERO (CRD42023494169).ResultsOur study found that in the group of patients who achieved very good partial response (VGP